It can also invade deep pockets of the bone called canalicular networks and be present within the bone for long periods of time. "Our study highlights that osteocyte lacuno-canalicular networks ...

Nordic Pharma plans to announce commercialization details in the near future for the dry eye disease treatment ...

Nordic Group B.V., an international pharmaceutical company operating as Nordic Pharma, announced today that Lacrifill®, a novel therapy for dry eye, has just received CE mark approval. This ...